Literature DB >> 29904419

Value of procalcitonin for diagnosing perioperative pneumonia, urinary infections and superficial surgical site infections in patients undergoing primary hip and knee arthroplasty.

Lixuan Zhang1,2, Daozhang Cai1, Hanming Guo2.   

Abstract

Serum procalcitonin (PCT) levels may be helpful for the diagnosis of infections during the perioperative period of arthroplasty. However, there is much debate in the literature regarding the appropriate cut-off value for different types of surgery and local bacterial infection. The present study aimed to evaluate serum PCT levels in patients undergoing arthroplasty and to determine the cut-off value that may represent perioperative pneumonia, urinary infections and superficial surgical site infections. The present retrospective study included a total of 500 patients treated between July 2014 and August 2015. The case group contained 25 patients with perioperative infections (pneumonia, urinary and superficial surgical site infections), and the control group contained 25 patients without any post-surgical complications. Serum levels of PCT and white blood cells (WBC) were measured pre-operatively (D0) and at post-operative D4, D6 and D8, and the sensitivity, specificity and predictive value of these parameters were assessed. Regarding the comparison of the mean PCT levels between the case and the control group, a significant difference was seen at D8 (P=0.007), while no significant differences were observed at D0 (P=0.010), D4 (P=0.069) and D6 (P=0.093). No statistically significant differences in WBC levels between groups were observed for (P>0.01). In the control group, the PCT levels at D4 (0.062±0.020 ng/ml) were 2-fold of the mean baseline value, followed by a decrease until D6 (0.051±0.019 ng/ml) and a return close to the normal range by D8 (0.032±0.015 ng/ml). The PCT levels in the case group had rapidly increased on D4 (0.510±1.208 ng/ml). In contrast to the control group, they continuously increased on D6 (0.527±1.360 ng/ml) and D8 (0.686±1.117 ng/ml). From a clinical point of view, infection events were indicated in these patients during post-operative follow-up. For PCT, the area under the receiver operating characteristic curve (AUC) was 0.978 [95% confidence interval (CI), 0.933-1.022], and for WBC, the AUC was 0.562 (95% CI, 0.398-0.0.726). Based on the above data, the PCT value was a significant predictor of infection (AUC>0.9). For PCT, the cut-off point of 0.0995 ng/ml was associated with a sensitivity of 96% and a specificity of 100%. However, WBC were not a significant predictor of infection (0.5<AUC<0.7), and the cut-off value of 7.05×109/l was associated with a sensitivity of 64% and a specificity of 44%. In conclusion PCT was found to be a promising marker for diagnosing bacterial infections post-arthroplasty due to its high specificity. Based on the sensitivity and the specificity, detecting PCT may be more valuable than using WBC in the diagnosis of sepsis-associated pathological changes in the perioperative period.

Entities:  

Keywords:  arthroplasty; perioperative infection; procalcitonin; white blood cell count

Year:  2018        PMID: 29904419      PMCID: PMC5996668          DOI: 10.3892/etm.2018.6124

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  45 in total

1.  Serological detection of Gram-positive bacterial infection around prostheses.

Authors:  M Rafiq; T Worthington; S E Tebbs; R B Treacy; R Dias; P A Lambert; T S Elliott
Journal:  J Bone Joint Surg Br       Date:  2000-11

Review 2.  The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist.

Authors:  John G Laffey; John F Boylan; Davy C H Cheng
Journal:  Anesthesiology       Date:  2002-07       Impact factor: 7.892

3.  Sepsis biomarkers.

Authors:  John Pramod; Akashdeep Singh
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

4.  Dynamics of serum procalcitonin in patients after major neurosurgery.

Authors:  G Laifer; M Wasner; P Sendi; P Graber; O Gratzl; P Huber; U Fluckiger; W Zimmerli
Journal:  Clin Microbiol Infect       Date:  2005-08       Impact factor: 8.067

Review 5.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

6.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

7.  Increasing risk of revision due to deep infection after hip arthroplasty.

Authors:  Håvard Dale; Geir Hallan; Geir Hallan; Birgitte Espehaug; Leif I Havelin; Lars B Engesaeter
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

8.  Serum procalcitonin for discrimination between septic and non-septic arthritis.

Authors:  T Hügle; P Schuetz; B Mueller; G Laifer; A Tyndall; S Regenass; T Daikeler
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

9.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

10.  Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.

Authors:  N Boussekey; O Leroy; H Georges; P Devos; T d'Escrivan; B Guery
Journal:  Infection       Date:  2005-08       Impact factor: 3.553

View more
  2 in total

1.  Neutrophil extracellular trap formation index predicts occurrences of deep surgical site infection after laparotomy.

Authors:  Zehua Duan; Shilong Sun; Cheng Qu; Kai Wang; Fang Chen; Xinyu Wang; Chengnan Chu; Baochen Liu; Jieshou Li; Weiwei Ding
Journal:  Ann Transl Med       Date:  2021-09

2.  Serum Procalcitonin Levels in Postoperative Monitoring of Diabetic Patients with Posterior Lumber Vertebral Stabilization Surgery: A Prospective Comparative Study.

Authors:  İbrahim Hakkı Tör; Sedef Gülçin Ural
Journal:  Turk J Anaesthesiol Reanim       Date:  2022-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.